project id: TCGA-KIRP; case submitter id: TCGA-SX-A7SM; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.93; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.59; rna integrity number: 8.9; age at index: 60; days to birth: -22044; days to death: 363; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Dead; year of birth: 1952; year of death: 2012; age at diagnosis: 22044; ajcc clinical m: M1; ajcc clinical n: N1; ajcc clinical stage: Stage IV; ajcc clinical t: T3a; ajcc pathologic m: M1; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; is ffpe: false; composition: Not Reported; days to collection: 380; days to sample procurement: 0; initial weight: 140.0; portion submitter id: TCGA-SX-A7SM-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0;